In an innovative clinical trial led by UCSF, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer.
April 01, 2014
Doctors should focus on life expectancy when deciding whether to order mammograms for their oldest female patients, since the harms of screening likely outweigh the benefits unless women are expected to live at least another decade, according to a review of the scientific literature by experts at UCSF and Harvard medical schools.
March 27, 2014
The stiffening of breast tissue in breast-cancer development points to a new way to distinguish a type of breast cancer with a poor prognosis from a related, but often less deadly type, UCSF researchers have found in a new study.
March 17, 2014
One of the world’s preeminent cancer scientists, Alan Ashworth, PhD, FRS, has been appointed the new director of the UCSF Helen Diller Family Comprehensive Cancer Center.
February 03, 2014
New guidelines recommending screening mammography every two years for women ages 50 to 74 would save the United States $4.3 billion a year in health care costs, according to a UCSF-led study.
October 03, 2013
Often deadly “triple-negative” breast cancers might be effectively treated in many cases with a drug that targets a previously unknown vulnerability in the tumors, UCSF reports.
July 29, 2013
A group of scientists convened by the National Cancer Institute and chaired by a UCSF breast cancer expert is proposing a major update of the way the nation approaches diseases now classified as “cancer.”
April 16, 2013
A new UCSF study has found a clear association between certain genes and the development of lymphedema, a painful and chronic condition that often occurs after breast cancer surgery and some other cancer treatments.
March 18, 2013
Screening for breast cancer every two years appears just as beneficial as yearly mammograms for women ages 50 to 74, with significantly fewer “false positives” – even for women whose breasts are dense or who use hormone therapy for menopause.
February 05, 2013
Among older women, getting a mammogram every two years was just as beneficial as getting a mammogram annually, and led to significantly fewer false positive results, according to a study led by UCSF.